Statement of Organization, Functions, and Delegations of Authority, 397-398 [2013-31206]
Download as PDF
<![CDATA[
397
Federal Register / Vol. 79, No. 2 / Friday, January 3, 2014 / Notices
table below account for about half of the
total participants in the CWHSP.
• Pathologist Invoice—42 CFR 37.202
specifies procedures for the NCWAS.
The invoice submitted by the
pathologist must contain a statement
that the pathologist is not receiving any
other compensation for the autopsy.
Each participating pathologist may use
their individual invoice as long as this
statement is added. It is estimated that
only 5 minutes is required for the
pathologist to add this statement to the
standard invoice that they routinely use.
• Pathologist Report—42 CFR 37.203
provides the autopsy specifications. The
pathologist must submit information
found at autopsy, slides, blocks of
tissue, and a final diagnosis indicating
presence or absence of pneumoconiosis.
The format of the autopsy reports are
variable depending on the pathologist
conducting the autopsy. Since an
autopsy report is routinely completed
by a pathologist, the only additional
burden is the specific request for a
clinical abstract of terminal illness and
final diagnosis relating to
pneumoconiosis. Therefore, only 5
minutes of additional burden is
estimated for the pathologist’s report.
• Consent, Release and History Form
(2.6)—This form documents written
authorization from the next-of-kin to
perform an autopsy on the deceased
miner. A minimum of essential
information is collected regarding the
deceased miner including the
occupational history and smoking
history. From past experience, it is
estimated that 15 minutes is required for
the next-of-kin to complete this form.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden/
response
(in hrs)
Total burden
(in hrs)
Type of respondents
Form name
Coal Mine Operators .........................
X-ray Facility Supervisor ...................
X-ray—Coal Miners ...........................
Coal Miners .......................................
B Reader Physicians ........................
Physicians taking the B Reader Examination.
Spirometry Test—Coal Miners ..........
Pathologist ........................................
Pathologist ........................................
Form 2.10 .........................................
Form 2.11 .........................................
No form required ..............................
Form 2.9 ...........................................
Form 2.8 ...........................................
Form 2.12 .........................................
200
100
5,000
5,000
10,000
100
1
1
1
1
1
1
30/60
30/60
15/60
20/60
3/60
10/60
100
50
1,250
1,667
500
17
2,500
5
5
1
1
1
20/60
5/60
5/60
833
1
1
Next-of-kin for deceased miner ........
No form required ..............................
Invoice—No standard form ..............
Pathology Report—No standard
form.
Form 2.6 ...........................................
5
1
15/60
1
Total ...........................................
...........................................................
........................
........................
........................
4,420
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–31464 Filed 1–2–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
mstockstill on DSK4VPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part F of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services, Centers for Medicare &
Medicaid Services (CMS), (last amended
at Federal Register, Vol. 76, No. 75, pp.
21908–21909, dated April 19, 2011, and
Vol. 77, No. 140, p. 42740, dated July
20, 2012) is amended to reflect the
abolishment of the Office of Public
Engagement (OPE). The Offices of
Hearings and Inquiries (OHI) was
VerDate Mar<15>2010
16:36 Jan 02, 2014
Jkt 232001
established and reports directly to the
Chief Operating Officer (COO).
CMS modified its structure to: (1)
Conduct Marketplace eligibility appeals;
(2) assist Medicare beneficiaries with
complaints, inquiries, and grievances,
and to gather the information necessary
to file Medicare appeals; and (3)
conduct administrative hearings for
institutional appeals which fall under
the jurisdiction of the Provider
Reimbursement Review Board, the
Medicare Geographic Classification
Review Board, and the CMS Hearings
Officers.
The functions in OPE include the
Medicare Ombudsman, tribal affairs,
and emergency preparedness and
continuity of operations. The Medicare
Ombudsman was moved to OHI, tribal
affairs was moved to the Center for
Medicaid and CHIP Services (CMCS),
and emergency preparedness and
continuity of operations was moved to
the Consortium for Quality
Improvement and Survey & Certification
Operations (CQISCO). In addition, the
Office of Marketplace Eligibility
Appeals was established in OHI, and the
Office of Hearings was moved from the
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Office of Operations Management
(OOM) to OHI.
Part F., Section FC. 10 (Organization)
is revised as follows:
Office of the Administrator (FC)
Office of Equal Opportunity and Civil
Rights (FCA)
Office of Legislation (FCC)
Office of the Actuary (FCE)
Office of Strategic Operations and
Regulatory Affairs (FCF)
Center for Clinical Standards and
Quality (FCG)
Center for Medicare (FCH)
Center for Medicaid and CHIP Services
(FCJ)
Center for Strategic Planning (FCK)
Center for Program Integrity (FCL)
Chief Operating Officer (FCM)
Office of Minority Health (FCN)
Center for Medicare and Medicaid
Innovation (FCP)
Federal Coordinated Health Care Office
(FCQ)
Center for Consumer Information and
Insurance Oversight (FCR)
Office of Communications (FCT)
Delegations of Authority
All delegations and re-delegations of
authority made to officials and
employees of affected organizational
E:\FR\FM\03JAN1.SGM
03JAN1
398
Federal Register / Vol. 79, No. 2 / Friday, January 3, 2014 / Notices
components will continue in them or
their successor organization pending
further re-delegation, provided they are
consistent with the movement of
functions.
Authority: 44 U.S.C. 3101.
Dated: December 24, 2013.
Marilyn Tavenner,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2013–31206 Filed 1–2–14; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Risk Communications Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Risk
Communications Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on February 3 and 4, 2014, from 9
a.m. to 5 p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/default.htm; under
the heading ‘‘Resources for You,’’ click
on ‘‘Public Meetings at the FDA White
Oak Campus.’’ Please note that visitors
to the White Oak Campus must enter
through Building 1.
Contact Person: Luis G. Bravo, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 3274,
Silver Spring, MD 20993–0002, 240–
402–5274, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area). A notice in the Federal Register
about last minute modifications that
impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
VerDate Mar<15>2010
16:36 Jan 02, 2014
Jkt 232001
should always check the Agency’s Web
site at https://www.fda.gov/Advisory
Committees/default.htm and scroll
down to the appropriate advisory
committee meeting link, or call the
advisory committee information line to
learn about possible modifications
before coming to the meeting.
If you are unable to join us in person,
we encourage you to watch the Webcast.
Visit the Risk Communication Advisory
Committee Web site at https://
www.fda.gov/AdvisoryCommittees/
CommitteesMeetingMaterials/Risk
CommunicationAdvisoryCommittee/
default.htm. The link will become
active shortly before the open session
begins at 9 a.m.
Agenda: On February 3 and 4, 2014,
the committee will meet to discuss
methods for identifying the impact and
increasing the reach of communications
on topics of interest to consumers. The
discussion will also address how FDA
can evaluate whether its ‘‘Consumer
Updates’’ (https://www.fda.gov/For
Consumers/ConsumerUpdates/
default.htm) are reaching the targeted
population, and whether they are
increasing awareness and understanding
of the key risk messages. The discussion
will also assess whether the
communications are having the
intended impact on knowledge,
behaviors, or outcomes.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before January 27, 2014.
Oral presentations from the public will
be scheduled between approximately 1
p.m. and 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before January
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
17, 2014. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by January 21, 2014.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Luis G. Bravo
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: December 30, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2013–31486 Filed 1–2–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995), the
Health Resources and Services
Administration (HRSA) announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
SUMMARY:
E:\FR\FM\03JAN1.SGM
03JAN1
]]>Agencies
[Federal Register Volume 79, Number 2 (Friday, January 3, 2014)]
[Notices]
[Pages 397-398]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-31206]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
Statement of Organization, Functions, and Delegations of
Authority
Part F of the Statement of Organization, Functions, and Delegations
of Authority for the Department of Health and Human Services, Centers
for Medicare & Medicaid Services (CMS), (last amended at Federal
Register, Vol. 76, No. 75, pp. 21908-21909, dated April 19, 2011, and
Vol. 77, No. 140, p. 42740, dated July 20, 2012) is amended to reflect
the abolishment of the Office of Public Engagement (OPE). The Offices
of Hearings and Inquiries (OHI) was established and reports directly to
the Chief Operating Officer (COO).
CMS modified its structure to: (1) Conduct Marketplace eligibility
appeals; (2) assist Medicare beneficiaries with complaints, inquiries,
and grievances, and to gather the information necessary to file
Medicare appeals; and (3) conduct administrative hearings for
institutional appeals which fall under the jurisdiction of the Provider
Reimbursement Review Board, the Medicare Geographic Classification
Review Board, and the CMS Hearings Officers.
The functions in OPE include the Medicare Ombudsman, tribal
affairs, and emergency preparedness and continuity of operations. The
Medicare Ombudsman was moved to OHI, tribal affairs was moved to the
Center for Medicaid and CHIP Services (CMCS), and emergency
preparedness and continuity of operations was moved to the Consortium
for Quality Improvement and Survey & Certification Operations (CQISCO).
In addition, the Office of Marketplace Eligibility Appeals was
established in OHI, and the Office of Hearings was moved from the
Office of Operations Management (OOM) to OHI.
Part F., Section FC. 10 (Organization) is revised as follows:
Office of the Administrator (FC)
Office of Equal Opportunity and Civil Rights (FCA)
Office of Legislation (FCC)
Office of the Actuary (FCE)
Office of Strategic Operations and Regulatory Affairs (FCF)
Center for Clinical Standards and Quality (FCG)
Center for Medicare (FCH)
Center for Medicaid and CHIP Services (FCJ)
Center for Strategic Planning (FCK)
Center for Program Integrity (FCL)
Chief Operating Officer (FCM)
Office of Minority Health (FCN)
Center for Medicare and Medicaid Innovation (FCP)
Federal Coordinated Health Care Office (FCQ)
Center for Consumer Information and Insurance Oversight (FCR)
Office of Communications (FCT)
Delegations of Authority
All delegations and re-delegations of authority made to officials
and employees of affected organizational
[[Page 398]]
components will continue in them or their successor organization
pending further re-delegation, provided they are consistent with the
movement of functions.
Authority: 44 U.S.C. 3101.
Dated: December 24, 2013.
Marilyn Tavenner,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2013-31206 Filed 1-2-14; 8:45 am]
BILLING CODE 4120-01-P
